New Graft for Dialysis Access in Kidney Failure
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a new type of graft (aXess) for dialysis access in people with kidney failure who cannot get a fistula. The graft is placed in the arm to help with blood flow during dialysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have end-stage kidney disease (kidney failure) and need a graft for dialysis, but a fistula (a direct connection between an artery and vein) is not an option for you.
- You are at least 18 years old.
- Your arm veins and arteries are large enough (at least 4mm) for the study graft.
- You are willing and able to come to follow-up visits for at least 1 year after the procedure.
- You do not have severe heart disease, uncontrolled diabetes, active infection, a bleeding disorder, or upcoming kidney transplant within 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of dialysis access graft (called aXess-E) for people with kidney failure who need a graft in their arm. It aims to see if the graft works well for long-term dialysis.
This study follows people with kidney failure who need dialysis access, when they receive an AV (artery-to-vein) access graft made from a processed donor artery. It’s meant to track safety and how well the new graft performs in real-world care.
This study tests whether a special ultrasound implant (EchoMark) helps a new dialysis fistula mature properly. It involves people with advanced kidney disease who are starting or already on dialysis and are having a fistula created in the upper arm.
This study looks at blood flow and sounds in new arteriovenous fistulas (AVFs) during dialysis. If you need a new AVF in your forearm, this trial may help doctors understand how to make your fistula work better.
This Phase 1 study tests a treatment (called AMSCs) to help stop scar-like narrowing at the connection point of a new arm dialysis fistula. If it works and is safe, it could improve long-term fistula function so dialysis can work better.
This study tests whether an “AV graft” implant works safely and well for people with end-stage kidney disease who need hemodialysis. It may help your dialysis access last and work better, compared with current expectations for AV grafts.
Hear when a new End Stage Renal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.